Upstream of mTOR, the PI3K/AKT pathway is influenced by PTEN, the negative regulator of PI3K signaling, which decreases its expression in many cancers including pancreatic, and may be downregulated through several mechanisms including mutation, deletion, and methylation (15). This evidence concerns the gene AKT1 and cancer.